Tuberc Respir Dis.  2005 Oct;59(4):413-417.

Insidious Onset of Amiodarone Pulmonary Toxicity Presented with Hemoptysis

Affiliations
  • 1Department of Internal Medicine, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea. jbh@gnah.co.kr
  • 2Department of Diagnostic Radiology, University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea.
  • 3Department of Diagnostic Pathology University of Ulsan, Gangneung Asan Hospital, Gangneung, Korea.

Abstract

Amiodarone is widely used to control fatal arrhythmia. However, amiodarone therapy is associated with a relatively high incidence of pulmonary toxicity, up to 5 to 10%. Typical symptoms are nonspecific and often manifest as nonproductive cough, dyspnea and interstitial infiltrates in patients with acute pneumonitis or chronic fibrosis. However, hemoptysis is a very rare symptom of amiodarone pulmonary toxicity. We report a case of amiodarone pulmonary toxicity, who presented with hemoptysis and was successfully treated with the cessation of amiodarone, with review of the relevant literature.

Keyword

Amiodarone pulmonary toxicity; Hemoptysis; Acute pneumonitis

MeSH Terms

Amiodarone*
Arrhythmias, Cardiac
Cough
Dyspnea
Fibrosis
Hemoptysis*
Humans
Incidence
Pneumonia
Amiodarone
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr